off
Morning Buzz: Aerie Pharmaceuticals (AERI), Cablevision Systems (CVC), Oracle
In a dramatic turnaround for Irvine, CA-based Aerie, which was forced to concede that its first Phase III had failed to hit the primary endpoint last April, the FDA provided written approval in June to change the primary endpoint for their second late-stage study-Rocket...
Posted On Sep 20 2015
